Lotte Sahin Levison

Lotte Sahin Levison

Auto-generated profile, based on publicly available information

Lotte Sahin Levison

Department of Neurology, Aarhus University Hospital, Aarhus, Denmark

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Pediatric Neurology
Verified
Journal Article
Closed access
LLLotte Sahin Levison
Lotte Sahin Levison
RTReimar Wernich Thomsen
Reimar Wernich Thomsen
LMLars Kjøbsted Markvardsen
Lars Kjøbsted Markvardsen
DCDiana Hedevang Christensen
Diana Hedevang Christensen
SSSøren Hein Sindrup
Søren Hein Sindrup
HAHenning Andersen
Henning Andersen

12 December 2024 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
LLLotte Sahin Levison
Lotte Sahin Levison
JBJakob Udby Blicher
Jakob Udby Blicher
HAHenning Andersen
Henning Andersen
Background and aim Recent studies have suggested that the incidence rate (IR) and the rate of death (MR) of amyotrophic lateral sclerosis (ALS) are increasing. Still, it remains unclear whether this is due to improved case ascertainment or represents a true increase. We examined the development in the incidence and mortality of ALS in Denmark for 42 years. Methods We retrieved individual-level data of all patients aged above 18 years with first-time ALS diagnosed at any Danish department of neurology. The IR and MR were calculated based on data from 1980 to 2021, stratified by gender and age. Results We identified 5,943 patients with ALS and identified a total of 5,069 deaths in the nationwide population. Overall, the IR was 3.4 per 100,000 persons per year (95% CI 3.4–3.5). ALS incidence rose gradually during the study period, and the IR was 2.8 times higher (95% CI 2.4–3.2) when comparing the latest period (2018–2021) with the first (1980–1983). Parallel to the IR, the MR increased over time and was associated with male gender and rose with age at diagnosis, peaking in the 70–79-year age group. Conclusion In Denmark, the IR and MR of ALS increased threefold from 1980 to 2021, with steadily increasing risk related to male gender and in particular to higher age. Considering our aging societies, the number of elderly patients with ALS can be expected to increase considerably.

1 April 2019 in Clinical Epidemiology
Verified
Journal Article
Open access
PDF file
LLLotte Sahin Levison
Lotte Sahin Levison
RTReimar Wernich Thomsen
Reimar Wernich Thomsen
DCDiana Hedevang Christensen
Diana Hedevang Christensen
TMThomas Mellemkjær
Thomas Mellemkjær
SSSøren Hein Sindrup
Søren Hein Sindrup
HAHenning Andersen
Henning Andersen
Purpose: To validate the diagnostic codes for Guillain-Barré syndrome (GBS) in the Danish National Patient Registry (DNPR). Secondly, to examine 30-year trends in the incidence of GBS in Denmark. Patients and methods: We used the DNPR to identify all patients aged 16 and above diagnosed with a primary GBS diagnosis at any Danish department of neurology between 1987 and 2016. Medical files were reviewed according to the clinical criteria of the National Institute of Neurological Disorders and Stroke Committee and classified according to the Brighton criteria. The incidence rate (IR) was calculated based on data from 1987 to 2016 and stratified by season, gender, and age. Results: Over 30 years, we identified 2,319 patients aged 16 and above in the DNPR. From a validation cohort of 573 patients, we were able to retrieve 425 (74.2%) medical files; 356 GBS diagnoses were confirmed. The overall positive predictive value was 83.8% (95% confidence interval (CI): 80.0–87.0). In 99% of the confirmed patients, the Brighton criteria level 1–3 for GBS were met. The IR was fairly stable over 30 years at 1.77 per 100,000 person years (95% CI: 1.70–1.84). The incidence was higher in the winter season (IR ratio compared with summer: 1.18 (95% CI: 1.09–1.29)), and was strongly associated with male gender (IR ratio vs females: 1.44 (95% CI: 1.33–1.57)). IRs rose with age at diagnosis, particularly after the age of 50 in both men and women and a minor peak was observed for total IR in young adults. Conclusion: Primary diagnostic codes for GBS at Danish departments of neurology have high validity. The DNPR is a well-suited data source for epidemiological research on GBS. The Danish nationwide 30-year GBS IR is stable over time and similar to GBS IRs reported in other European and North American populations.

12 April 2022 in Neurology
Verified
Journal Article
Closed access
PDF file
LLLotte Sahin Levison
Lotte Sahin Levison
RTReimar Wernich Thomsen
Reimar Wernich Thomsen
SSSøren Hein Sindrup
Søren Hein Sindrup
HAHenning Andersen
Henning Andersen
Background and objectives: Cancer may increase the risk of developing Guillain-Barré syndrome (GBS) due to molecular mimicry or immunosuppression, but the exact relationship is unclear. We aimed to determine the association between incident cancer and the following risk of GBS development. Methods: We conducted a nationwide population-based case-control study of all patients with first-time hospital-diagnosed GBS in Denmark between 1987 and 2016 and 10 age, sex and index date-matched population controls per case. We identified incident cancer diagnoses between six months prior to and two months after the GBS index date. We used conditional logistic regression to compute ORs as a measure of relative risk and performed stratified analyses to assess the impact of cancer on GBS risk in strata of calendar-periods, sex and age. In sensitivity analyses, to assess any potential risk of survival bias induced by including cancer diagnoses potentially made after GBS diagnosis, we examined incident cancers in both a broader exposure window (one year before to three months after GBS index date) and a narrower window (six months to one month before the GBS index date). Results: Of the 2,414 patients with GBS and 23,909 controls included, 49 cases (2.0%) and 138 controls (0.6%) had a recent cancer diagnosis, respectively, yielding a matched odds ratio (OR) of 3.6 (95% confidence interval (CI), 2.6- 5.1) for GBS associated with cancer. Stratification by calendar time, gender and age showed robust results for the association between cancer and GBS, with no major variations. Broadening and narrowing the exposure window produced slightly weakened associations of OR, 2.4 (95% CI, 1.8-3.3) and OR, 2.5 (95% CI, 1.5-4.1), respectively. The GBS ORs were highest for cancers of the lymphatic and hematopoietic tissue (OR, 7.2; 95% CI, 2.9-18.0), respiratory tract (OR, 5.6; 95% CI, 2.7-11.9), prostate and other male genital organ (OR, 5.0; 95% CI, 2.1-11.6) and breast cancer (OR, 5.0; 95% CI, 1.7-14.5). Discussion: In this large nationwide epidemiologic study, incident cancer was associated with a markedly increased risk of subsequent GBS development. The results suggest that yet unidentified factors present in several types of cancer drive this association.

13 August 2022 in European Journal of Neurology
Verified
Journal Article
Open access
LLLotte Sahin Levison
Lotte Sahin Levison
RTReimar Wernich Thomsen
Reimar Wernich Thomsen
HAHenning Andersen
Henning Andersen
Background and purpose: Influenza vaccination may increase the risk of developing Guillain–Barré syndrome (GBS) due to an elicited immune response, but the exact magnitude and duration of risk is unclear and hence the aim of this study.Methods: We conducted a retrospective nationwide population‐based case–control study of prospectively collected data on all patients with first‐time hospital‐diagnosed GBS in Denmark between 2002 and 2016 and 10 age‐, sex‐ and index date‐matched population controls per case. The primary exposure was incident influenza vaccination 1 month prior to admission with GBS. We used medical registries to ascertain a complete hospital contact history of pre‐existing morbidities. To examine duration of GBS risk, we repeated the analysis for five consecutive 1‐month risk periods following vaccination.Results: Of the 1295 GBS cases and 12,814 controls, 20 cases (1.5%) and 119 controls (0.9%) had received an influenza vaccination within the last month, yielding a comorbidity‐adjusted odds ratio of 1.9 (95% confidence interval 1.1–3.2) for GBS. Stratified analyses by calendar time, gender and age showed similar results. The increased risk of GBS was largely confined to 1 month following influenza vaccination. The population‐attributable fraction of GBS from influenza vaccination in Denmark was 0.4%.Conclusions: Influenza vaccination was associated with a slightly elevated risk of GBS occurrence within 1 month after vaccination. However, only 1.5% of GBS cases in Denmark are associated with recent influenza vaccination. Thus, the benefit of influenza vaccines in preventing influenza infections and associated morbidity and mortality needs to be weighed against the small absolute risk of GBS.

5 July 2023 in European Journal of Neurology
Verified
Journal Article
Open access
LLLotte S. Levison
Lotte S. Levison
RTReimar W. Thomsen
Reimar W. Thomsen
HAHenning Andersen
Henning Andersen
Background and purpose: This study was undertaken to determine the association of hospital‐diagnosed morbidity and recent surgery with risk of subsequent Guillain–Barré syndrome (GBS) development.Methods: We conducted a nationwide population‐based case–control study of all patients with first‐time hospital‐diagnosed GBS in Denmark between 2004 and 2016 and 10 age‐, sex‐, and index date‐matched population controls per case. Hospital‐diagnosed morbidities included in the Charlson Comorbidity Index were assessed as GBS risk factors up to 10 years prior to the GBS index date. Incident major surgery was assessed within 5 months prior.Results: In the 13‐year study period, there were 1086 incident GBS cases, whom we compared with 10,747 matched controls. Any pre‐existing hospital‐diagnosed morbidity was observed in 27.5% of GBS cases and 20.0% of matched controls, yielding an overall matched odds ratio (OR) of 1.6 (95% confidence interval [CI] = 1.4–1.9). The strongest associations were found for leukemia, lymphoma, diabetes, liver disease, myocardial infarction, congestive heart failure, and cerebrovascular disease, with 1.6‐ to 4.6‐fold increased risks of subsequent GBS. GBS risk was strongest for morbidities newly diagnosed during the past 5 months (OR = 4.1, 95% CI = 3.0–5.6). Surgical procedures within 5 months prior were observed in 10.6% of cases and 5.1% of controls, resulting in a GBS OR of 2.2 (95% CI = 1.8–2.7). Risk of developing GBS was highest during the first month following surgery (OR = 3.7, 95% CI = 2.6–5.2).Conclusions: In this large nationwide study, individuals with hospital‐diagnosed morbidity and recent surgery had a considerably increased risk of GBS.